
Ocugen Provides Business Update and Second Quarter 2020 Financial Results
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) reported second quarter 2020 financial results along with a general business update.
Read MoreChester County News and Community Website
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) reported second quarter 2020 financial results along with a general business update.
Read MoreMALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing transformative therapies to cure blindness diseases, announced the U.S. Food and Drug Administration (FDA) …
Read MoreMALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing transformative therapies to cure blindness diseases, announced the U.S. Food and Drug Administration (FDA) …
Read MoreMALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a clinical-stage company focused on discovering, developing and commercializing transformative therapies to treat the whole eye, today announced the decision to discontinue the …
Read MoreMALVERN, PA — Ocugen, Inc., (NASDAQ: OCGN), a clinical-stage company focused on discovering, developing and commercializing transformative therapies to treat rare and underserved ophthalmic diseases, announced the publication in Nature Gene Therapy …
Read More